MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Rejection of tumor cells in vitro: morphological studies on killer T cells and damaged tumor cells.
Natural killer cells and tumor metastasis.
The effect of tumor necrosis factor-alpha on human malignant glial cells.
In vitro effects of tumor necrosis factor-alpha on human thyroid follicular cells.
Effect of tumor necrosis factor on the human fibrinolytic system.
Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells?
Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.
Effects of opioid therapy on human natural killer cells.
Tumor necrosis factor-alpha in human milk.
Tumor necrosis factor in human disease.
Expression of Fc mu receptors on human natural killer cells.
Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli.
Interleukin-1 alpha and tumor necrosis factor-alpha protect cells against natural killer cell-mediated cytotoxicity and natural killer cytotoxic factor.
Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.
Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.
An important role of tumor necrosis factor receptor-2 on natural killer T cells on the development of dsRNA-enhanced Th2 cell response to inhaled allergens.
Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation.
Human Adaptive Natural Killer Cells: Beyond NKG2C.
The autocrine role of tumor necrosis factor in the proliferation and functional differentiation of human lymphokine-activated T killer cells (T-LAK) in vitro.
Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.
Natural killer cell immunotherapy to target stem-like tumor cells.
Augmentation by tumor necrosis factor alpha of the systemic therapeutic effect of lymphokine-activated killer cells in adoptive immunotherapy of murine tumor.
Tumor necrosis factor stimulates osteoclastogenesis from human bone marrow cells under hypoxic conditions.
tumor necrosis factor-beta on human lymphokine-activated killer cells.
A membrane-associated lymphotoxin (LT)-related molecule was detected on human lymphokine-activated killer (LAK) cells by flow cytometric analysis. Kin...
247KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Rejection of tumor cells in vitro: morphological studies on killer T cells and damaged tumor cells.
Natural killer cells and tumor metastasis.
The effect of tumor necrosis factor-alpha on human malignant glial cells.
In vitro effects of tumor necrosis factor-alpha on human thyroid follicular cells.
Effect of tumor necrosis factor on the human fibrinolytic system.
Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells?
Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.
Effects of opioid therapy on human natural killer cells.
Tumor necrosis factor-alpha in human milk.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms